The administrative core will function as a resource to assist project and core leaders, and all personnel for administrative tasks associated with this program project. It serves a vital function to facilitate and allow investigators to focus as much attention on scientific and research activities. The core will ensure efficient and timely execution of scientific, budgetary and administrative requirements and deadlines associated with the program project. The communication and coordination of these administrative activities by the core will be paramount in reaching the objectives and goals of the program project. Goal and Objectives: The goal of Administrative Core A is to provide administrative support for all investigators participating in this translational Program Project grant. This goal will be achieved by addressing the following objectives: Objective 1: To provide administrative support for budgetary and personnel resource management Objective 2: To provide administrative support for the coordination of scientific and review meetings Objective: To provide administrative support for regulatory and scientific reporting of research activities

Public Health Relevance

The administrative core will provide administrative support for all investigators participating in this translational Program Project grant. It serves a vital function to facilitate and allow investigators to focus as much attention on scientific and research activities. The core will ensure efficient and timely execution of scientific, budgetary and administrative requirements and deadlines associated with the program project.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL108801-03
Application #
8526536
Study Section
Special Emphasis Panel (ZHL1-PPG-A)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
3
Fiscal Year
2013
Total Cost
$161,199
Indirect Cost
$70,891
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Ma, Kevin C; Schenck, Edward J; Pabon, Maria A et al. (2018) The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness. Am J Respir Crit Care Med 197:300-309
Schenck, Edward J; Oromendia, Clara; Torres, Lisa K et al. (2018) Rapidly Improving ARDS in Therapeutic Randomized Controlled Trials. Chest :
Schenck, Edward J; Ma, Kevin C; Murthy, Santosh B et al. (2018) Danger Signals in the ICU. Crit Care Med 46:791-798
Ghanta, Sailaja; Kwon, Min-Young; Rosas, Ivan O et al. (2018) Mesenchymal Stromal Cell Therapy: Does the Source Matter? Crit Care Med 46:343-345
Baron, Rebecca M; Kwon, Min-Young; Castano, Ana P et al. (2018) Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis. J Leukoc Biol 104:677-689
Shu, Chang; Huang, He; Xu, Ying et al. (2018) Pressure Overload in Mice With Haploinsufficiency of Striated Preferentially Expressed Gene Leads to Decompensated Heart Failure. Front Physiol 9:863
Harrington, John S; Schenck, Edward J; Oromendia, Clara et al. (2018) Acute respiratory distress syndrome without identifiable risk factors: A secondary analysis of the ARDS network trials. J Crit Care 47:49-54
Siempos, Ilias I; Ma, Kevin C; Imamura, Mitsuru et al. (2018) RIPK3 mediates pathogenesis of experimental ventilator-induced lung injury. JCI Insight 3:
Rosas, Ivan O; Goldberg, Hilary J; Collard, Harold R et al. (2018) A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis. Chest 153:94-104
Chen, Xi; Wang, Shaojun; Xu, Haiwei et al. (2017) Evidence for a retinal progenitor cell in the postnatal and adult mouse. Stem Cell Res 23:20-32

Showing the most recent 10 out of 85 publications